The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Key Points: RN-1 treatment of SCD mice results in increased human fetal γ-globin induction and fetal hemoglobin synthesis. RN-1 treatment of SCD mice significantly reduces sickling, hemolysis, and tissue injury with no obvious adverse side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Histone H3 Lysine 4 Demethylation Is a Target of Nonselective Antidepressive Medications
Lee, M. G., Wynder, C., Schmidt, D. M., McCafferty, D. G., & Shiekhattar, R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.004 · Cited by 438
Self-citationCorrection of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., et al. (2011) · Science · doi:10.1126/science.1211053 · Cited by 326 · cited 1×
“Themagnitude of g-globin induction in the SCD mouse by RN-1 is comparable with that previously reported for decitabine orHU in transgenicmousemodels.(50,51) Notably, RN-1 treatment robustly increased the expression of murine embryonic ey- and bh1-globin genes (Figure 1E-F).”
MethodCorepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Xu, J., Bauer, D. E., Kerenyi, M. A., Vo, T. D., Hou, S., Hsu, Y.-J., Yao, H., Trowbridge, J. J., Mandel, G., & Orkin, S. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303976110 · Cited by 233 · cited 4×
“However, because a growing number of nuclear receptors as well as other transcription factors have been shown to associate with LSD1, these effects could be mediated through any of these other DNA-binding proteins.(25,31) The ChIP analyses reported here showed that the chromatin occupancy of one LSD1 cofactor, CoREST,…”
BackgroundInfluentialFAD-dependent lysine-specific demethylase-1 regulates cellular energy expenditure
Hino, S., Sakamoto, A., Nagaoka, K., Anan, K., Wang, Y., Mimasu, S., Umehara, T., Yokoyama, S., Kosai, K.-I., & Nakao, M. (2012) · Nature Communications · doi:10.1038/ncomms1755 · Cited by 226 · cited 3×
“Genome-wide analyses of LSD1-regulated genes revealed that PGC-1a is a direct target gene of LSD1, and loss of LSD1 function in adipocytes was shown to induce the expression of PGC-1a.(48) We recently showed that PGC-1a is also required formurine erythropoiesis and globin gene regulation, and that PGC-1a knock-outmice…”
BackgroundInfluentialLevels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell Disease
Noguchi, C. T., Rodgers, G. P., Serjeant, G., & Schechter, A. N. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801143180207 · Cited by 222 · cited 2×
“Clinical data indicate that induction of HbF to a three- to fivefold increase over the normal baseline in patients can significantly alleviate the clinical manifestations of SCD.(3,4) The cumulative abundance of human and mouse early globin mRNAs maximally attained in SCD mice was 15% (Figure 1G) of all globin transcr…”
BackgroundPolanowska-Grabowska, R., Wallace, K., Field, J. J., Chen, L., Marshall, M. A., Figler, R., Gear, A. R. L., & Linden, J. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.211615 · Cited by 189 · cited 1×
“Complete blood cell counts performed on RN-1–treated mice showed that they had slightly elevated numbers of RBCs, more hemoglobin (HGB), elevated hematocrit (HCT), and white blood cell count (WBC), including lymphocytes, but lower platelets (PLT) and neutrophils (Neut), which were elevated in SCD mice when compared wi…”
BackgroundLysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
Shi, L., Cui, S., Engel, J. D., & Tanabe, O. (2013) · Nature Medicine · doi:10.1038/nm.3101 · Cited by 172 · cited 3×
“differentiated human CD34(1) cells in vitro.(30) Thus, the inhibition of LSD1 activity presents a novel exploratory avenue as a therapeutic strategy to treat SCD.”
BackgroundSelf-citation
Cited by
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Recent progress in understanding and manipulating haemoglobin switching for the haemoglobinopathies
Vinjamur, D. S., Bauer, D. E., & Orkin, S. H. (2018) · British Journal of Haematology · doi:10.1111/bjh.15038 · Cited by 114
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Lettre, G., & Bauer, D. E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01341-0 · Cited by 104
Metadata
- Authors
- Cui, S., Lim, K.-C., Shi, L., Lee, M., Jearawiriyapaisarn, N., Myers, G., Campbell, A., Harro, D., Iwase, S., Trievel, R. C., Rivers, A., DeSimone, J., Lavelle, D., Saunthararajah, Y., & Engel, J. D.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-07-16
- Volume
- 126
- Issue
- 3
- Pages
- 386-396
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1524961767
- Cited by
- 98
- References
- 9
- FWCI
- 6.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice. https://app.cochat.ai/papers/10.1182/blood-2015-02-626259
- The paper
- Cui, S., Lim, K.-C., Shi, L., Lee, M., Jearawiriyapaisarn, N., Myers, G., Campbell, A., Harro, D., Iwase, S., Trievel, R. C., Rivers, A., DeSimone, J., Lavelle, D., Saunthararajah, Y., & Engel, J. D. (2015). The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice. Blood. https://doi.org/10.1182/blood-2015-02-626259
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.